MOUNT SOLEIL LIMITED

Financial Health Assessment: Mount Soleil Limited

1. Financial Health Score: B-

Explanation: Mount Soleil Limited is akin to a patient with a very strong skeleton but severely anemic blood flow. The company possesses substantial underlying net worth (£1.26 million) and has no long-term debt, which provides excellent structural strength. However, it suffers from acute short-term illiquidity, with current liabilities marginally exceeding current assets. The company is "asset rich, cash poor," meaning that while it could survive a major illness, a sudden, minor cash emergency could cause significant distress.

2. Key Vital Signs

• Net Worth (Equity): £1,265,523
  • Interpretation: Excellent. The company’s net assets have grown substantially from £519,725 in 2021 to over £1.2 million in 2022. This is primarily due to a massive capital injection rather than trading profits.
• Liquidity (Current Ratio): 0.99
  • Interpretation: Critical. Current Assets (£31,624) are slightly less than Current Liabilities (£31,803). A healthy current ratio is typically between 1.2 and 2.0. A ratio below 1.0 indicates that if all short-term debts were called in tomorrow, the company could not pay them using its liquid assets.
• Cash Reserves: £25,879
  • Interpretation: Weak. For a company with over £1.2 million in net assets, holding less than £26k in the bank leaves it highly vulnerable to unexpected costs. It is surviving on a financial drip feed.
• Asset Composition: £1,265,702 in Fixed Assets
  • Interpretation: Over 97% of the company’s assets are locked up in tangible assets (likely property, given the nature of the business) and long-term investments. This is the root cause of the liquidity issue—all the health is locked in the bones, none is in the bloodstream.

3. Diagnosis

Condition: "Illiquid Wealth" Syndrome (Asset-Rich, Cash-Poor)

The financial data reveals a business that has undergone a significant structural transformation in 2022, shifting from a previously declining asset base to a highly capitalised, investment-heavy vehicle.

Symptoms Analysis: * The Capital Transfusion: In 2022, the company issued shares at a massive premium, injecting £747,500 into the share premium account. This was a healthy move that boosted equity. * The Arterial Blockage: However, rather than using this cash to fund operations or build a cash buffer, the company immediately redirected £750,000 into fixed-asset investments. While investments can be healthy, diverting almost all available cash into long-term holdings has starved the operating business of working capital. * The Intangible Write-Off: The company wrote off its entire intangible asset balance (trademarks valued at £825k) by changing its amortisation schedule from 20 years to 10 years. While this is an accounting policy change that cleans up the balance sheet, it highlights that past asset valuations were overly optimistic. * Stagnant Operations: The Profit & Loss reserve actually decreased slightly from £512,225 to £508,023, indicating that the core operating business made a small loss over the year. The "physical well-being activities" are not currently generating the cash needed to sustain the company's daily pulse.

4. Prognosis

Outlook: Stable, but vulnerable to short-term shocks.

The long-term prognosis for Mount Soleil Limited is positive due to its robust equity base and valuable underlying assets. The controlling shareholders (corporate entities based in Denmark and the UK) have demonstrated a willingness to inject capital.

However, the short-term prognosis is fragile. The lack of working capital means the company is highly susceptible to even minor cash flow fevers. If trade creditors demand payment or if an unexpected operational expense arises, the company may be forced into a "fire sale" of its long-term investments or property to raise cash, which could result in losses.

5. Recommendations

To improve its financial wellness and build resilience, Mount Soleil Limited should consider the following treatments:

1. Establish a Cash Buffer (Financial Immune System Boost): Retain a minimum of 3-6 months of operating expenses in an easy-access cash reserve. This will cure the negative working capital and protect against short-term shocks without needing to liquidate investments.
2. Review Investment Liquidity: Ensure that the £750,000 investment can be quickly liquidated if necessary. If it is tied up in a private entity with no resale market, the company is effectively holding a blocked artery. Consider shifting a portion into more liquid, short-term asset classes.
3. Working Capital Management: Negotiate longer payment terms with suppliers (creditors) to ease the immediate cash drain, and ensure that any income from the "physical well-being" operations or investment dividends is retained in the business rather than distributed.
4. Operational Health Check: Conduct a review of the core trading activities (SIC Code 96040). The operating business is currently making a small loss. Management must diagnose why the core activity is not generating positive cash flow and adjust the business model accordingly.